Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 727-728, October 2007

After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome

Department of Radiology University of California, San Diego La Jolla, California 92093-0819

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(07)00184-9

doi:10.1016/j.nucmedbio.2007.07.004

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 727-728, October 2007

Article Tools